• Home
  • About
    • Company Overview
    • Contact Information & Distributors
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Expertise
    • Intellectual Property
    • Careers
  • Research
    • Regenerative medicine
    • Research Services
  • Products
    • Lab-on-a-tip
    • BioPen Systems
    • Biopixlar Platform
    • Biopixlar AER
    • Biozone 6
    • Dynaflow Resolve System
    • Consumables
    • Accessories
  • News
    • Company News
    • Investor Newsletter
    • Upcoming Events
  • Investor Relations
    • Press Releases
    • Företrädesemission 2022
    • Documents
    • Financial Calendar
    • Management & Board
    • Company Presentation
    • Share Owners
    • Certified Adviser
  • CONTACT US
Fluicell
  • Home
  • About
    • Company Overview
    • Contact Information & Distributors
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Expertise
    • Intellectual Property
    • Careers
  • Research
    • Regenerative medicine
    • Research Services
  • Products
    • Lab-on-a-tip
    • BioPen Systems
    • Biopixlar Platform
    • Biopixlar AER
    • Biozone 6
    • Dynaflow Resolve System
    • Consumables
    • Accessories
  • News
    • Company News
    • Investor Newsletter
    • Upcoming Events
  • Investor Relations
    • Press Releases
    • Företrädesemission 2022
    • Documents
    • Financial Calendar
    • Management & Board
    • Company Presentation
    • Share Owners
    • Certified Adviser
  • CONTACT US
  • November 13, 2019

Roland Malli’s Lab from Medical University of Graz

“For the application of expensive substances or small amounts of reagents, it’s challenging to use perfusion systems. Using…

Read more
  • June 17, 2019

Veronica Jove from the Rockefeller University

«The BioPen product is well designed and works even better than we could have hoped. The scientist who…

Read more
  • January 14, 2019

Associate Prof. Kent Jadermark from Karolinska Institutet

“We have tested the BioPen in different applications here at Karolinska Institutet and in collaboration with a research…

Read more
  • January 14, 2019

Dr. Niek Welkenhuysen from Chalmers University

“The major advantages of the BioPen system for us is that it is rather smooth to set up…

Read more
  • January 14, 2019

Dr. Joseph Bruton from Karolinska Institutet

“I chose the BioPen System because I can target precise areas of the cell and see how local…

Read more
  • January 14, 2019

Prof. Rizzo from the University of Maryland Medical Center

“The main uses of the Biopen is for stimulating migrating cells. The benefits when using the system is…

Read more
  • January 14, 2019

U.S. Food and Drug Administration

“We have a need for the BioPen System to be used for studying variations in cell contractility due…

Read more
  • January 14, 2019

Dr. Dani Cai from the National Institutes of Health

“The BioPen System is one of the best single-cell treatment system on the market. It is easy-to-use, and…

Read more
Expertise logo

Expertise

We are a pioneer in open-volume microfluidics for life science. Our team of specialists are able to support you to get the most of our products.

Customer Service Icon

Customer service

Our professional team are ready to assist you. We speak English, Swedish, Chinese, French, Russian and Polish. We are dedicated to respond within 24h.

CE marking
LEGAL AND SALES
CUSTOMER SUPPORT
Fluicell’s compliance with GDPR
Twitter linkedin youtube

Adress

Flöjelbergsgatan 8C
SE – 431 37 Mölndal, Sweden

Phone

+46 762 08 33 54

info@fluicell.com

Meta info

Corporate ID: 556889-3282

VAT: SE556889328201

Fluicell®, Biopen®, Biozone 6®, Biopixlar® and Lab-on-a-tip® are registered trademarks of Fluicell AB, Sweden.
Webmaster:
mkmedia
Disclaimer